{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-002246","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.952764+00:00","generated_at":"2026-06-10T04:12:15.221843+00:00","sec_items":["1.01","2.01","9.01","3.01","3.02","3.03","5.01","5.02","5.03","5.06"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Envoy Medical closes Anzu merger; $25M redeemed, $10M PIPE, 19.5M shares outstanding","bullets":["Consideration to Envoy stockholders: 14,999,990 shares of Class A common stock.","Approximately $25.0M redeemed by Anzu public stockholders at ~$10.46 per share.","PIPE: $10M from 1M Series A Preferred at $10.00/share; additional 1M Series A to GAT Funding.","Post-close: 19,549,982 Class A shares, 4,500,000 Series A preferred, 14,166,666 warrants.","Shares and warrants trade on Nasdaq starting Oct 2 under COCH and COCHW."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-002246","json":"https://secwatch.observer/filing/0001013762-23-002246.json","markdown":"https://secwatch.observer/filing/0001013762-23-002246.md","text":"https://secwatch.observer/filing/0001013762-23-002246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/ea186352-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:12:15.221843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"022f01a010","claim":"Whitney Haring-Smith resigned as Chairman at Envoy Medical, Inc..","evidence_excerpt":"Charles Brynelsen replaced Whitney Haring-Smith as chairman","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"},{"claim_id":"272d58c2f0","claim":"Glen A. Taylor was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"276b0a9343","claim":"Diane Dewbrey resigned as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3388a0810c","claim":"Daniel Hirsch resigned as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"45b82b1147","claim":"Brent Lucas was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"54791f1529","claim":"Mona Patel was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5e3cb599b8","claim":"Daniel Hirsch resigned as other_named_officer at Envoy Medical, Inc..","evidence_excerpt":"each of Whitney Haring-Smith and Daniel Hirsch resigned as executive officers","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"681ff12567","claim":"Whitney Haring-Smith was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6b7c305176","claim":"Brent Lucas was appointed as Chief Executive Officer at Envoy Medical, Inc..","evidence_excerpt":"Brent Lucas was appointed to serve as the Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6e74c93c93","claim":"Charles Brynelsen was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"80a53a5ae5","claim":"Susan J. Kantor was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a64152177a","claim":"Janis Smith-Gomez was elected as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cec040a1e6","claim":"David R. Wells was appointed as Chief Financial Officer at Envoy Medical, Inc..","evidence_excerpt":"David R. Wells was appointed to serve as the Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d0da645bf6","claim":"Charles Brynelsen was appointed as Chairman at Envoy Medical, Inc..","evidence_excerpt":"Charles Brynelsen appointed as chairman of the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"},{"claim_id":"d1dbac03b2","claim":"Whitney Haring-Smith resigned as other_named_officer at Envoy Medical, Inc..","evidence_excerpt":"each of Whitney Haring-Smith and Daniel Hirsch resigned as executive officers","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"},{"claim_id":"e2957848ce","claim":"Priya Cherian Huskins resigned as Director at Envoy Medical, Inc..","evidence_excerpt":"each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5f5ec12832551b2e5eb5bf9bd31291404dfff967","claim":"Envoy Medical, Inc.: Adopted amended and restated bylaws effective September 29, 2023 (effective 2023-09-29).","evidence_excerpt":"On the Closing Date, in connection with the consummation of the Business Combination, the Company adopted the Second Amended and Restated Certificate of Incorporation (as amended and restated, the “ Charter ”) and amended and restated bylaws (as amended and restated, the “ Bylaws ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.97,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"governance_change"},{"claim_id":"88f651989406ea4896b2772bada3c3ae118b2805","claim":"Envoy Medical, Inc.: Company ceased being a shell company as a result of the Business Combination (effective 2023-09-29).","evidence_excerpt":"As a result of the Business Combination, the Company ceased being a shell company.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.99,"family_label":"Governance Changes","details":[{"label":"Change","value":"shell status"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"governance_change"},{"claim_id":"b8205c97fa37dff60b97baf95898a01410e93505","claim":"Envoy Medical, Inc.: Adopted Second Amended and Restated Certificate of Incorporation effective September 29, 2023, including amendments proposed by Charter Proposals (effective 2023-09-29).","evidence_excerpt":"On the Closing Date, in connection with the consummation of the Business Combination, the Company adopted the Second Amended and Restated Certificate of Incorporation (as amended and restated, the “ Charter ”) and amended and restated bylaws (as amended and restated, the “ Bylaws ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.98,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"governance_change"},{"claim_id":"303cc1a828c61b70c693f6ad0b0b2f51f029db0a","claim":"Envoy Medical, Inc. underwent a change of control involving Envoy Medical Corporation for Each share of Envoy Common Stock converted into the right to receive a number of shares of New Envoy Common Stock equal to the Exchange Ratio of 0.063603; Spons (closed 2023-09-29).","evidence_excerpt":"share of Envoy Common Stock was converted into the right to receive pursuant to the applicable provisions of the Business Combination Agreement. The Exchange Ratio was equal to 0.063603. In addition, pursuant to the subscription agreement, dated April 17, 2023 (as amended to date, the “ Subscription Agreement ”), by and between Anzu and Anzu SPAC GP I LLC (the “","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000101376223002246/0001013762-23-002246-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"Envoy Medical Corporation"},{"label":"Consideration","value":"Each share of Envoy Common Stock converted into the right to receive a number of shares of New Envoy Common Stock equal to the Exchange Ratio of 0.063603; Spons"},{"label":"Closing","value":"2023-09-29"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}